TARTARUS BEERS LIMITED

Company number 13496573 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

TARTARUS BEERS LIMITED - Analysis Report

Company Number: 13496573

Analysis Date: 2025-07-29 15:06 UTC

Financial Health Assessment for Tartarus Beers Limited


1. Financial Health Score: D

Explanation:
Tartarus Beers Limited exhibits symptoms of financial distress, primarily due to persistent negative working capital and a recent shift from positive to negative net equity. The company's liquidity position is weak, and its solvency is under pressure. While the business remains operational and growing its workforce, the financial "vital signs" indicate caution is needed to avoid further deterioration.


2. Key Vital Signs

Metric 2024 Value Interpretation
Fixed Assets £120,761 Moderate investment in long-term assets, stable but reduced from prior year (£159k).
Current Assets £105,445 Increased slightly, mostly short-term resources like cash and stock.
Current Liabilities £201,104 High short-term debts, exceeding current assets significantly.
Net Current Assets (Working Capital) -£94,806 Negative working capital—sign of liquidity strain; company may struggle to meet short-term obligations.
Total Assets Less Current Liabilities £25,955 Indicates some buffer after accounting for current debts, but reduced from previous year.
Creditors Due After One Year £45,236 Medium-term liabilities adding to financial burden.
Net Assets / Shareholders' Funds -£19,281 Negative equity, indicating liabilities exceed total assets—a critical symptom of financial stress.
Employee Count 3 (up from 2) Small but growing workforce, suggesting operational activity.

3. Diagnosis

The company’s financial "vital signs" reveal several concerning symptoms:

  • Liquidity Stress: Negative net current assets highlight that Tartarus Beers Limited does not have sufficient short-term assets to cover its immediate debts. This is akin to a patient with a weak pulse and low blood pressure—warning signs that liquidity is not healthy.

  • Eroding Equity: The shift from positive net assets (£1,772 in 2023) to negative (-£19,281 in 2024) signals that the company is operating at a net deficit. This could be due to accumulated losses or increased liabilities, resembling a patient losing critical reserves needed for survival.

  • Increasing Long-Term Debt: Creditors due after more than one year have increased slightly, adding to the company’s financial obligations and potentially limiting future flexibility.

  • Asset Reduction: Fixed assets have decreased, which might indicate asset sales or depreciation outpacing reinvestment—potentially a "weight loss" symptom that could be either positive (cost control) or negative (asset stripping).

  • Operational Activity: The increase in employee headcount from 2 to 3 suggests ongoing business operations and potential growth, which is a positive sign amid financial challenges.

Overall, the company is in a fragile state—like a patient with an infection that has compromised vital organs. Without intervention, the risk of insolvency or severe financial distress is heightened.


4. Recommendations

To restore financial health and stabilize operations, consider the following targeted actions:

  • Improve Liquidity:

    • Accelerate collection of receivables and optimize inventory management to reduce working capital needs.
    • Negotiate extended payment terms with suppliers to better align cash inflows and outflows.
  • Restructure Debt:

    • Explore refinancing options to convert short-term liabilities into longer-term debt, easing immediate cash flow pressure.
    • Engage with creditors proactively to discuss possible debt rescheduling or payment holidays.
  • Increase Capital Injection:

    • Consider raising additional equity capital from existing shareholders or new investors to restore positive net assets and improve solvency.
    • Evaluate potential government grants or support schemes applicable to micro-manufacturers.
  • Cost Control and Profitability:

    • Conduct a detailed cost review to identify and cut non-essential expenses.
    • Focus on improving product margins through pricing strategies or operational efficiencies.
  • Financial Monitoring:

    • Implement more frequent cash flow forecasting and budget reviews to detect early signs of distress.
    • Regularly update stakeholders on financial status to maintain confidence.
  • Professional Advice:

    • Consult with insolvency practitioners or turnaround specialists early if cash flow issues persist. Preventative action is critical to avoid formal insolvency procedures.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.